UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
FBLG holding history
FibroBiologics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FBLG overviewAll 13F holders of FBLGFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,073
- Value
- $1.02K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,073 | $1.02K | <0.1% | −4,648−81.2% | Reduced | Holders |
| Q1 2026 | 5,721 | $7.55K | <0.1% | −318−5.3% | ReducedConverted for a 1-for-20 split | Holders |
| Q4 2025 | 120,770 | $27.2K | <0.1% | +43,336+56.0% | Added | Holders |
| Q3 2025 | 77,434 | $42.3K | <0.1% | −32,840−29.8% | Reduced | Holders |
| Q2 2025 | 110,274 | $68.6K | <0.1% | −2,585−2.3% | Reduced | Holders |
| Q1 2025 | 112,859 | $101.6K | <0.1% | −15,331−12.0% | Reduced | Holders |
| Q4 2024 | 128,190 | $256.4K | <0.1% | +84,838+195.7% | Added | Holders |
| Q3 2024 | 43,352 | $134.0K | <0.1% | −34,700−44.5% | Reduced | Holders |
| Q2 2024 | 78,052 | $389.5K | <0.1% | +78,024+278,657.1% | Added | Holders |
| Q1 2024 | 28 | $303 | <0.1% | +28 | New | Holders |